新里程：前三季度管理费用同比下降23%

Core Insights - The company announced a significant reduction in sales and management expenses in response to price declines following the centralized procurement of its product, Du Yi Wei [2] Group 1: Sales Expenses - Sales expenses primarily related to the pharmaceutical sector have decreased by 35% year-on-year in the first three quarters [2] Group 2: Management Expenses - Management expenses have also seen a reduction, with a year-on-year decrease of 23% in the first three quarters, achieved through various cost-cutting measures [2]